Changes in Hong Kong stocks | Tianxing Healthcare (01609) rose more than 36% during the intraday period and recently obtained EU MDR certification and product registration approvals in multiple overseas markets

The Zhitong Finance App learned that Tianxing Healthcare (01609) rose more than 36% during the intraday period. As of press release, it had risen 12.66% to HK$113, with a turnover of HK$71.653 million.

According to the news, Tianxing Medical announced that recently, the company received the EU New Medical Device Regulation (CE MDR) certification certificate, making it the first sports medicine manufacturer in China to obtain CE MDR certification for all products. The above certificate covers 15 types of products, including full suture anchors, full suture tabs, continuous stitched multi-needle meniscus, metal belt wire anchors, polyether ether ketone wire anchors, carbon fiber composite wire anchors, etc. These products include implants, active equipment and consumables, and endoscopic surgical instruments, which can provide overall clinical solutions for the six major joints of shoulder, knee, hip, elbow, wrist, and ankle.

At the same time, applications for registration of plasma surgery equipment, electrodes, full suture anchors, suture products, etc. submitted by the company in the United Kingdom, Australia, Brazil, Singapore, Malaysia, Thailand and other countries have been approved one after another, and registration certificates issued by the local competent authorities have been obtained. The acquisition of the above certification and registration certificates indicates that more of our products meet the regulatory requirements of the European Union and the above countries, which will help the company further expand its overseas business layout in the European Union, Latin America and Southeast Asia, and further enhance the company's competitiveness and product layout in the international market.